Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J. Balcer

Showing results (11-20 of 264) with videos related to

Pageof 27
Sort By:
Neurology|April 28, 2010
Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuityLaura J Balcer, Elliot M Frohman
Current Treatment Options in Neurology|December 11, 2003
Giant Cell ArteritisJennifer K. Hall, Laura J. Balcer
Ophthalmology Clinics of North America|September 1, 2004
Endocrine and metabolic deficiencyGregory F Wu, Laura J Balcer
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 19, 2014
The latest on optical coherence tomographyRobert C Sergott, Laura J Balcer
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2003
54th annual meeting of the American Academy of Neurology, Denver, Colorado, April 13-20, 2002Laura J Balcer, Mark L Moster
Journal of the Neurological Sciences|February 26, 2013
In reply: the King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohortLaura J Balcer, Steven L Galetta
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2017
The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - YesSteven L Galetta, Laura J Balcer
Current Treatment Options in Neurology|May 31, 2002
Idiopathic Intracranial HypertensionRobert K. Shin, Laura J. Balcer
Continuum (Minneapolis, Minn.)|August 7, 2013
Optic neuritis and the evaluation of visual impairment in multiple sclerosisRobert A Bermel, Laura J Balcer
Multiple Sclerosis and Related Disorders|April 17, 2015
Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trialsKristin M Galetta, Laura J Balcer
Pageof 27

Showing results (11-20 of 264) with videos related to

Sort By:
Pageof 27
Neurology|April 28, 2010
Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuityLaura J Balcer, Elliot M Frohman
Current Treatment Options in Neurology|December 11, 2003
Giant Cell ArteritisJennifer K. Hall, Laura J. Balcer
Ophthalmology Clinics of North America|September 1, 2004
Endocrine and metabolic deficiencyGregory F Wu, Laura J Balcer
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 19, 2014
The latest on optical coherence tomographyRobert C Sergott, Laura J Balcer
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2003
54th annual meeting of the American Academy of Neurology, Denver, Colorado, April 13-20, 2002Laura J Balcer, Mark L Moster
Journal of the Neurological Sciences|February 26, 2013
In reply: the King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohortLaura J Balcer, Steven L Galetta
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2017
The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - YesSteven L Galetta, Laura J Balcer
Current Treatment Options in Neurology|May 31, 2002
Idiopathic Intracranial HypertensionRobert K. Shin, Laura J. Balcer
Continuum (Minneapolis, Minn.)|August 7, 2013
Optic neuritis and the evaluation of visual impairment in multiple sclerosisRobert A Bermel, Laura J Balcer
Multiple Sclerosis and Related Disorders|April 17, 2015
Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trialsKristin M Galetta, Laura J Balcer
Pageof 27